HEM Pharma Inc. (KOSDAQ:376270)
22,400
+850 (3.94%)
At close: Nov 17, 2026
| Market Cap | 161.48B -18.7% |
| Revenue (ttm) | 16.14B +1.5% |
| Net Income | -20.87B |
| EPS | -2,926.56 |
| Shares Out | 7.21M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 9,470 |
| Open | 22,050 |
| Previous Close | 21,550 |
| Day's Range | 19,850 - 22,600 |
| 52-Week Range | 19,850 - 97,500 |
| Beta | 0.94 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 27, 2026 |